U.S. FDA declines to approve Ascendis' hormone disorder therapy
Ascendis Pharma A/S said on Monday the U.S. Food & Drug Administration had declined to approve the Danish drugmaker's experimental therapy to treat adult patients with a hormone disorder... | May 1, 2023